Lueurs et leurres de la santé globale À propos de MenAfriVac®, un vaccin « africain » contre la méningite
View/ Open
Date
2017-12Author
Thiongane, Oumy
Graham, Janice
Broutin, Hélène
Metadata
Show full item recordAbstract
In biomedical narratives, the Meningitis Vaccine Project (MVP) enabled the technology transfer for the development and implementation of MenAfriVac® vaccine at an affordable price for African countries. The presentation of MVP as a success story, however, may be more sociotechnical myth than fact. MenAfriVac® is far from being a silver bullet . While successful in eliminating Meningitis A, MVP rhetoric highlighting meningitis control obscured a more complex epidemiological context. This paper analyzes the discursive construction of success that supports global health single vaccine initiatives.
Citation
Thiongane, O., Graham, J. E., & Broutin, H. (2017). Lueurs et leurres de la santé globale: À propos de MenAfriVac®, un vaccin « africain » contre la méningite. Anthropologie & développement, 46-47(2017), 213-234 . doi: 10.4000/anthropodev.607